Jaykumar Thumar, MBBS, MD
Adjunct Assistant Professor
Research & Publications
Biography
News
Research Summary
Dr Thumar’s research primarily focuses on clinical and translational research in Gastrointestinal cancers.
Selected Publications
- Abstract A002: A phase II study of peri-operative modified FOLFIRINOX in localized pancreatic ductal adenocarcinoma (PDAC)Cecchini M, Salem R, Robert M, Czerniak S, Rajaei M, Townsend J, Blaha O, Zelterman D, Thumar J, Kortmansky J, Zaheer W, Fischbach N, Persico J, Stein S, Khan S, Cha C, Billingsley K, Kunstman J, Chowdhury S, Tseng R, Mauricio C, Yugawa D, Escobar-Hoyos L, Johung K, Wiess C, Spickard E, Aushev V, Laliotis G, Jurdi A, Liu M, Lacy J. Abstract A002: A phase II study of peri-operative modified FOLFIRINOX in localized pancreatic ductal adenocarcinoma (PDAC). Cancer Research 2024, 84: a002-a002. DOI: 10.1158/1538-7445.panca2023-a002.
- Abstract CT170: A phase 1/2 study of olaparib in combination with ramucirumab in metastatic gastric and gastroesophageal junction adenocarcinoma (GEJ)Cecchini M, Chao J, Shyr Y, Cleary J, Uboha N, Cho M, Shields A, Pant S, Goff L, Spencer K, Kim E, Hsu C, Stein S, Thumar J, Kortmansky J, Kunstman J, LoRusso P, Ivy P, Lacy J. Abstract CT170: A phase 1/2 study of olaparib in combination with ramucirumab in metastatic gastric and gastroesophageal junction adenocarcinoma (GEJ). Cancer Research 2022, 82: ct170-ct170. DOI: 10.1158/1538-7445.am2022-ct170.